PCME is an accredited provider specializing in innovative continuing medical education solutions.
PCME is an accredited provider specializing in innovative continuing medical education solutions.
Chemotherapy-induced nausea and vomiting (CINV) remains among the most feared side effects of chemotherapy for cancer patients. Over the past two decades, advances have been made in the understanding of CINV, resulting in the recognition of various CINV types and the identification of factors that increase the likelihood of nausea and/or vomiting following chemotherapy administration. However, despite recent progress, a significant number of patients still develop CINV – particularly in the setting of delayed emesis, multicycle-multicourse chemotherapy, and in the bone marrow transplant setting. Through this event, oncology nurses will be empowered to assess a patient's risk factors, identify the different subtypes and settings of CINV, and make educated decisions to help improve patient outcomes.
The emphasis of the program will be on reviewing and discussing realistic and complex patient scenarios. Patient Vignettes discussing chemotherapy treatment and Audience Response System questions are woven throughout the program to challenge participants with clinical questions surrounding each case. The most current information on patient assessment and risk stratification, guideline-driven management, and new agents and treatment strategies will be provided as tools to improve the overall quality of life of patients.
 |
Carrie Tompkins Stricker, PhD, RN, AOCN (Chair) (read bio) Oncology Nurse Practitioner, Abramson Cancer Center Clinical Assistant Professor, School of Nursing University of Pennsylvania Philadelphia, PA |
 |
Sally Barbour, PharmD, BCOP, CPP (read bio) Clinical Oncology Pharmacist Investigational Chemotherapy Service Duke Clinical Care Research Program Duke Comprehensive Cancer Center Durham, NC |
 |
Lisa Downs, MSN, CRNP (read bio) Coordinator, Lymphoma Program Hospital of the University of Pennsylvania Philadelphia, PA |
This program was developed for oncology nurses and other health care professionals treating cancer patients.
At the conclusion of this activity, participants should be able to demonstrate the ability to:
Medical Education Resources is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
This CE activity provides 1.5 contact hours. Provider approval expires July 31, 2010. Provider approved by the California Board of Registered Nursing, Provider #CEP 12299, for 1.5 contact hours.
It is the policy of Medical Education Resources (MER) to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty participating in our programs are expected to disclose any relationships they may have with commercial companies whose products or services may be mentioned so that participants may evaluate the objectivity of the presentations. In addition, any discussion of off-label, experimental, or investigational use of drugs or devices will be disclosed by each of the faculty members.
Meeting space has been assigned to provide a satellite symposium supported by Eisai via an unrestricted educational grant during the Oncology Nursing Society's (ONS) 34th Annual Congress, April 30 – May 3, 2009 in San Antonio, Texas. The Oncology Nursing Society's assignment of meeting space does not imply product endorsement nor does the Oncology Nursing Society assume any responsibility for the educational content of the symposium.
The faculty reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Carrie Tompkins Stricker, PhD, RN, AOCN: Speaker: Merck, Roche
Sally Barbour, PharmD, BCOP, CPP: Speaker: Amgen, UPA; Consultant: NCCN
Lisa Downs, MSN, CRNP: Speaker: Millenium Pharmaceuticals, Bayer, Celgene, Cephalon
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Robert Morris, PharmD; Kathy Merlo; Donna Fucello; Blair St. Amand: Nothing to Disclose
The contents of some CME/CE activities may contain discussions of non-approved or off label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an Adobe Flash Player. The Adobe Flash Player can be downloaded here.
Sponsored by  |
This program is supported through an educational grant from |
By clicking this button you are agreeing that you have read and understood the CE Statements above.
